Call for applications for a fully financed PhD fellowship
Primary hyperparathyroidism (PHPT) is an endocrine disease marked by elevated parathyroid hormone (PTH) and hypercalcemia, commonly due to hypersecretion from a single adenoma. Complications include osteoporosis, cardiovascular disease (CVD), renal calcifications, and neuropsychiatric symptoms. The only definitive cure is parathyroidectomy by which the affected gland(s) are removed by surgery.
In this project we aim to further address potential complications to PHPT with specific focus on the bone, but also CVD and renal consequences are elucidated. Performing a randomized clinical trial, effects of treatment with a bisphosphonate prior to parathyroidectomy are elucidated.
The applicants for this PhD position should hold a master’s degree in medicine.
Knowledge and experience in clinical research including good clinical practice (GCP) is a plus.
Of personal qualifications, we seek an applicant with good communication skills in Danish and English, ability to work independently while beeing a part of a team and being curious to learn new methods.
Please submit your application via this link. Application deadline is 25 November 2024 23:59 CET. Preferred starting date is 1 February 2025.
For information about application requirements and mandatory attachments, please see our application guide.
Please contact Professor Lars Rejnmark, rejnmark@clin.au.dk, for more information.
All interested candidates are encouraged to apply, regardless of their personal background. Salary and terms of employment are in accordance with applicable collective agreement.
